Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Merit Medical Systems Inc MMSI

Merit Medical Systems, Inc. is engaged in manufacturing and marketing of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac... see more

Recent & Breaking News (NDAQ:MMSI)

Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance

GlobeNewswire 4 days ago

Merit Medical Launches the Ventrax(TM) Delivery System

GlobeNewswire April 9, 2025

Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025

GlobeNewswire April 7, 2025

Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD

GlobeNewswire March 27, 2025

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

GlobeNewswire March 25, 2025

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

GlobeNewswire March 18, 2025

First Patient Enrolled in Merit Medical's PREEMIE Study

GlobeNewswire March 10, 2025

Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance

GlobeNewswire February 25, 2025

Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025

GlobeNewswire January 13, 2025

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis

GlobeNewswire December 20, 2024

Merit Medical Announces Resignation of President, Joseph Wright

GlobeNewswire December 16, 2024

Merit Medical's WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients

GlobeNewswire November 25, 2024

Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical

GlobeNewswire November 1, 2024

Merit Medical Reports Third Quarter 2024 Results and Raises Full-Year Guidance

GlobeNewswire October 30, 2024

Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024

GlobeNewswire October 8, 2024

Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical

GlobeNewswire September 17, 2024

Merit Medical's WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients

GlobeNewswire September 16, 2024

Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress

GlobeNewswire September 11, 2024

Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance

GlobeNewswire August 1, 2024

Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY(TM) Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings

GlobeNewswire August 1, 2024